These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 10063273)

  • 1. Antimicrobial susceptibilities of clinical isolates of vancomycin-resistant enterococci in Taiwan.
    Hsueh PR; Wu JJ; Lu JJ; Teng LJ; Luh KT
    J Formos Med Assoc; 1999 Jan; 98(1):45-8. PubMed ID: 10063273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimicrobial activity of quinupristin-dalfopristin (RP 59500, Synercid) tested against over 28,000 recent clinical isolates from 200 medical centers in the United States and Canada.
    Jones RN; Ballow CH; Biedenbach DJ; Deinhart JA; Schentag JJ
    Diagn Microbiol Infect Dis; 1998 Jul; 31(3):437-51. PubMed ID: 9635235
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Vancomycin-resistant enterococci: in vitro activity of quinupristin / dalfoprostin (RP 59500)].
    Betriu C; Valverde JF; Culebras E; Gómez M; Sánchez A; Palau ML; Picazo JJ
    Enferm Infecc Microbiol Clin; 1999; 17(7):335-9. PubMed ID: 10535185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of quinupristin/dalfopristin and other antibiotics against ampicillin-resistant enterococcus faecium.
    Wang FD; Liu IM; Liu CY
    Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):119-23. PubMed ID: 10677922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial susceptibility and species identification for clinical isolates of enterococci.
    Hsieh SR
    J Microbiol Immunol Infect; 2000 Dec; 33(4):253-7. PubMed ID: 11269371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Molecular characterization of vancomycin-resistant enterococci isolates].
    Liu YM; Cao B; Wang H; Li BB; Yang CX; Wang QT; Du XL; Li F; Wang SS; Qu SS
    Zhonghua Yi Xue Za Zhi; 2008 Mar; 88(11):760-3. PubMed ID: 18683685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotypes and genotypes of vancomycin-resistant enterococci isolated during long-term follow-up in a patient with recurrent bacteremia and colonization.
    Yeh KM; Lu JJ; Siu LK; Peng MY; Chang FY
    J Microbiol Immunol Infect; 2002 Dec; 35(4):243-8. PubMed ID: 12542250
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Australian Group on Antimicrobial Resistance Enterococcus Surveillance Programme annual report, 2010.
    Coombs GW; Pearson JC; Christiansen K; Gottlieb T; Bell JM; George N; Turnidge JD;
    Commun Dis Intell Q Rep; 2013 Sep; 37(3):E199-209. PubMed ID: 24890955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. European Glycopeptide Susceptibility Survey of gram-positive bacteria for 1995. European Glycopeptide Resistance Survey Study Group.
    Felmingham D; Brown DF; Soussy CJ
    Diagn Microbiol Infect Dis; 1998 Aug; 31(4):563-71. PubMed ID: 9764397
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug resistance of 100 clinical strains of Enterococcus spp].
    Sawicka-Grzelak A; Rokosz A; Luczak M
    Med Dosw Mikrobiol; 1999; 51(3-4):239-47. PubMed ID: 10803253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic activity against urinary tract infection (UTI) isolates of vancomycin-resistant enterococci (VRE): results from the 2002 North American Vancomycin Resistant Enterococci Susceptibility Study (NAVRESS).
    Zhanel GG; Laing NM; Nichol KA; Palatnick LP; Noreddin A; Hisanaga T; Johnson JL; Hoban DJ;
    J Antimicrob Chemother; 2003 Sep; 52(3):382-8. PubMed ID: 12888592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in-vitro activity of quinupristin/dalfopristin against Enterococcus spp.
    Williams JD; Maskell JP; Whiley AC; Sefton AM
    J Antimicrob Chemother; 1997 May; 39 Suppl A():41-6. PubMed ID: 9511061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial resistance of enterococci in Turkey.
    Kaçmaz B; Aksoy A
    Int J Antimicrob Agents; 2005 Jun; 25(6):535-8. PubMed ID: 15908184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobial susceptibility of enterococci in vitro.
    Tsaur SM; Chang SC; Luh KT; Hsieh WC
    J Formos Med Assoc; 1993 Jun; 92(6):547-52. PubMed ID: 8106043
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of vancomycin-resistant Enterococcus faecium isolates from the United States and their susceptibility in vitro to dalfopristin-quinupristin.
    Eliopoulos GM; Wennersten CB; Gold HS; Schülin T; Souli M; Farris MG; Cerwinka S; Nadler HL; Dowzicky M; Talbot GH; Moellering RC
    Antimicrob Agents Chemother; 1998 May; 42(5):1088-92. PubMed ID: 9593132
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular epidemiology and antibiotic susceptibility of enterococci in Cincinnati, Ohio: a prospective citywide survey.
    Perlada DE; Smulian AG; Cushion MT
    J Clin Microbiol; 1997 Sep; 35(9):2342-7. PubMed ID: 9276414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Epidemiological study on vancomycin-resistant enterococci from fecal samples in the east area of Japan].
    Oguri T; Misawa S; Nakamura A; Igari J; Ishii Y; Yamaguchi K
    Kansenshogaku Zasshi; 2001 Jul; 75(7):541-50. PubMed ID: 11521276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activities of quinupristin/dalfopristin and eight other antimicrobial agents against 360 clinical isolates from Korea.
    Hwang SH; Kim MN; Pai CH; Huh DH; Shin WS
    Yonsei Med J; 2000 Oct; 41(5):563-9. PubMed ID: 11079615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program.
    Deshpande LM; Fritsche TR; Moet GJ; Biedenbach DJ; Jones RN
    Diagn Microbiol Infect Dis; 2007 Jun; 58(2):163-70. PubMed ID: 17368801
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization of vancomycin-resistant Enterococcus spp. clinical isolates recovered from hospitalized patients among several medical institutions in China.
    Sun H; Wang H; Xu Y; Jones RN; Costello AJ; Liu Y; Li G; Chen M; Mendes RE
    Diagn Microbiol Infect Dis; 2012 Dec; 74(4):399-403. PubMed ID: 23099304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.